Jennison Associates
WVE icon

Jennison Associates’s Wave Life Sciences WVE Stock Holding History

Jennison Associates’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-75,435
Closed -$1.4M – 701
2017
Q2 		$1.4M Hold
75,435
– – ﹤0.01% 553
2017
Q1 		$2.07M Hold
75,435
– – ﹤0.01% 540
2016
Q4 		$1.97M Hold
75,435
– – ﹤0.01% 555
2016
Q3 		$2.45M Buy
+75,435
New +$1.78M ﹤0.01% 547
2016
Q2 		– Sell
-370,825
Closed -$5.12M – 662
2016
Q1 		$5.12M Buy
370,825
+1,576
+0.4% +$22K 0.01% 489
2015
Q4 		$5.77M Buy
+369,249
New +$5.79M 0.01% 511

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Jennison Associates's WVE Position: Q3 2017 in Review

Jennison Associates sold out of Wave Life Sciences (WVE) in Q3 2017, closing a stake of 75,435 shares — an estimated $1.4M sold.

Jennison Associates first reported a position in WVE in Q4 2015 and held it in 6 quarters. The position peaked at $5.77M in Q4 2015. 58 funds tracked by Wall St. Rank hold WVE as of Q3 2017.

  • Jennison Associates reported no remaining Wave Life Sciences position as of Q3 2017 after selling out during the quarter.
  • Jennison Associates sold 75,435 Wave Life Sciences shares in Q3 2017, an estimated $1.4M.
  • Jennison Associates first reported a position in Wave Life Sciences in Q4 2015 and held it in 6 quarters.
  • Jennison Associates's Wave Life Sciences position peaked at $5.77M in Q4 2015.
  • 58 funds tracked by Wall St. Rank held Wave Life Sciences as of Q3 2017.

Based on Jennison Associates's 13F filing for Q3 2017, filed 3 Nov 2017.